ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $59,000 | +22.9% | 630 | -21.2% | 0.03% | +10.7% |
| Q3 2021 | $48,000 | -12.7% | 800 | 0.0% | 0.03% | -9.7% |
| Q2 2021 | $55,000 | -1.8% | 800 | 0.0% | 0.03% | -13.9% |
| Q1 2021 | $56,000 | -8.2% | 800 | 0.0% | 0.04% | -18.2% |
| Q4 2020 | $61,000 | +1.7% | 800 | 0.0% | 0.04% | -20.0% |
| Q3 2020 | $60,000 | +20.0% | 800 | 0.0% | 0.06% | 0.0% |
| Q2 2020 | $50,000 | +47.1% | 800 | 0.0% | 0.06% | +27.9% |
| Q1 2020 | $34,000 | -5.6% | 800 | 0.0% | 0.04% | +43.3% |
| Q4 2019 | $36,000 | -47.8% | 800 | -46.7% | 0.03% | -54.5% |
| Q3 2019 | $69,000 | -21.6% | 1,500 | 0.0% | 0.07% | -22.4% |
| Q2 2019 | $88,000 | +31.3% | 1,500 | 0.0% | 0.08% | +23.2% |
| Q1 2019 | $67,000 | – | 1,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |